Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ALLOALLO
Showing 8 of 29 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ALLOGENE THERAPEUTICS INC

BNP PARIBAS FINANCIAL MARKETS holds 56,759 shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $118,059 as of 2026-Q2. The position was decreased (-20.0% shares).

Current Value

$118,059

Current Shares

56,759

Total Value Change

-$11,788

Total Shares Change

+10,385

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
56,759
-20.0%
$118,0590.0%$2.08
0
2026-Q1
Decreased
70,965
-92.1%
$173,1550.0%$2.53
0
2025-Q4
Increased
900,424
+0.7%
$1.2M0.0%$1.31
25
2025-Q3
Increased
894,314
+1.7%
$1.1M0.0%$1.27
26
2025-Q2
Increased
878,987
+0.8%
$993,2550.0%$1.18
25
2025-Q1
Increased
871,597
+2.6%
$1.3M0.0%$1.55
26
2024-Q4
Increased
849,658
+1732.2%
$1.8M0.0%$2.10
42
2024-Q3
Increased
46,374
+541.5%
$129,8470.0%$2.91
36

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used